CEACAM5 and cyst: The current standard of care for risk stratifying PCLs involves the use of endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA) and analysis of cyst fluid, including measurements of carcinoembryonic antigen (CEA), cytology, amylase, and glucose levels.